Josh Riggs

CIK: 0001956391

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (25.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (25.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

IMDX

Insight Molecular Diagnostics Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (4 total)

IMDX
Insight Molecular Diagnostics Inc.
Mar 26, 2026
Exercise(M)
Direct
47.2K shares-
IMDX
Insight Molecular Diagnostics Inc.
Mar 26, 2026
Tax Payment(F)
Direct
12.3K shares at avg. $4.11$51K
IMDX
Insight Molecular Diagnostics Inc.
Sep 28, 2025
Award(A)
Option to Purchase Common Stock
Direct
400K shares-
OCX
Oncocyte Corp
Mar 26, 2025
Award(A)
Restricted Stock Units
Direct
188.7K shares-

		Type	Shares	Price		Ownership
Mar 26, 2026	IMDX Insight Molecular Diagnostics Inc.	Exercise(M)	47,170	-	$0	Direct
Mar 26, 2026	IMDX Insight Molecular Diagnostics Inc.	Tax Payment(F)	12,310	$4.11	$50,594	Direct
Sep 28, 2025	IMDX Insight Molecular Diagnostics Inc.	Award(A) Option to Purchase Common Stock	400,000	-	-	Direct
Mar 26, 2025	OCX Oncocyte Corp	Award(A) Restricted Stock Units	188,679	-	-	Direct

1-4 of 4 transactions

About Riggs Josh

Riggs Josh (SEC CIK 0001956391) files insider reports with the SEC as CEO and President of Insight Molecular Diagnostics Inc. (IMDX).

Signal8 holds 3 ownership filings by Riggs Josh, all Form 4s, filed between Mar 28, 2025 and Mar 30, 2026. Those filings report 4 transactions, from Mar 26, 2025 to Mar 26, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Riggs Josh's filings is in NASHVILLE, TN.

Recent filings by Riggs Josh

Mar 26, 2026: Option exercise of IMDX shares (Form 4, code M).
Mar 26, 2026: Tax withholding of IMDX shares (Form 4, code F).
Sep 28, 2025: Grant or award of IMDX derivative securities (Form 4, code A).
Mar 26, 2025: Grant or award of OCX derivative securities (Form 4, code A).

Other insiders filing for Insight Molecular Diagnostics Inc. (IMDX)

SILVERMAN LOU, Director
Last Andrew J., Director
Arno Andrew, Director
BROADWOOD PARTNERS, L.P., 10% Owner
James Andrea S., Chief Financial Officer
Liu James Yang, VP ACCT, Cntlr, Treasurer, PAO

How to read Form 4 transaction codes